Bouchey Financial Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Bouchey Financial Group’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13,018	Closed	-$74K	–	68
2016 Q2	$74K	Hold	13,018	–	–	0.03%	62
2016 Q1	$74K	Hold	13,018	–	–	0.03%	63
2015 Q4	$74K	Sell	13,018 -1,774	-12%	-$8.53K	0.03%	60
2015 Q3	$84K	Hold	14,792	–	–	0.04%	60
2015 Q2	$84K	Hold	14,792	–	–	0.04%	67
2015 Q1	$84K	Hold	14,792	–	–	0.04%	64
2014 Q4	$84K	Hold	14,792	–	–	0.04%	59
2014 Q3	$84K	Hold	14,792	–	–	0.04%	63
2014 Q2	$84K	Hold	14,792	–	–	0.05%	62
2014 Q1	$107K	Sell	14,792 -46	-0.3%	-$273	0.07%	59
2013 Q4	$73K	Buy	+14,838	New	+$57.4K	0.05%	57

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bouchey Financial Group's NWBO Position: Q3 2016 in Review

Bouchey Financial Group sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2016, closing a stake of 13,018 shares — an estimated $74K sold.

Bouchey Financial Group first reported a position in NWBO in Q4 2013 and held it in 11 quarters. The position peaked at $107K in Q1 2014. 54 funds tracked by Wall St. Rank hold NWBO as of Q3 2016.

Bouchey Financial Group reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q3 2016 after selling out during the quarter.
Bouchey Financial Group sold 13,018 Northwest Biotherapeutics, Inc. Common stock shares in Q3 2016, an estimated $74K.
Bouchey Financial Group first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2013 and held it in 11 quarters.
Bouchey Financial Group's Northwest Biotherapeutics, Inc. Common stock position peaked at $107K in Q1 2014.
54 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2016.

Based on Bouchey Financial Group's 13F filing for Q3 2016, filed 11 Oct 2016.